The products include JHP-Rodler, Betadorm D, Rhinopront, Collomack Topical, Tirgon and Xitix.
Recordati chairman and CEO Giovanni Recordati said, "The OTC pharmaceutical segment in Germany is worth around EUR 4 billion and represents a share in units of 52% of the overall pharmaceutical market."
JHP-Rodler is mint oil indicated for digestive disorder, headache, cough and cold, Betadorm D isDiphenhydramine HCl indicated for sleep disorders and Rhinopront, pseudoephedrine+triprolidine, is indicated for rhinitis and head colds.
The Collomack topical, salicylic acid solution, is an anti- corn preparation, Tirgon is bisacodyl for constipation and Xitix vitamin C lozenges to treat vitamin C deficiency.